Consistently, Ou et al. suggested the E2F1 expression was aberrantly upregulated in patients with acute myeloid leukemia, especially in those patients who had a mutation of FLT3-ITD (Ou et al., 2023). The gene discussed is E2F1; the disease is acute myeloid leukemia.